Flavoenzyme-mediated reduction reactions and antitumor activity of nitrogen-containing tetracyclic ortho-quinone compounds and their nitrated derivatives.

阅读:11
作者:Peciukaityte-Alksne Milda, Å arlauskas Jonas, Miseviciene Lina, Maroziene Audrone, Cenas Narimantas, KrikÅ¡topaitis Kastis, Staniulyte Zita, Anusevicius Žilvinas
Nitrogen-based tetracyclic ortho-quinones (naphtho[1'2':4.5]imidazo[1,2-a]pyridine-5,6-diones, NPDOs) and their nitro-substituted derivatives (nitro-(P)NPDOs) were obtained by condensation of substituted 2,3-dichloro-1,4-naphthoquinones with 2-amino-pyridine and -pyrimidine and nitration at an elevated temperature. The structural features of the compounds as well as their global and regional electrophilic potency were characterized by means of DFT computation. The compounds were highly reactive substrates of single- and two-electron (hydride) - transferring P-450R (CPR; EC 1.6.2.4) and NQO-1 (DTD; EC 1.6.99.2), respectively, concomitantly producing reactive oxygen species. Their catalytic efficiency defined in terms of the apparent second-order rate constant (k(cat)/K(M (Q))) values in P-450R- and NQO-1-mediated reactions varied in the range of 3-6 × 10(7) M(-1) s(-1) and 1.6-7.4 × 10(8) M(-1) s(-1), respectively. The cytotoxic activities of the compounds on tumor cell lines followed the concentration-dependent manner exhibiting relatively high cytotoxic potency against breast cancer MCF-7, with CL(50) values of 0.08-2.02 µM L(-1) and lower potency against lung cancer A-549 (CL(50) = 0.28-7.66 µM L(-1)). 3-nitro-pyrimidino-NPDO quinone was the most active compound against MCF-7 with CL(50) of 0.08 ± 0.01 µM L(-1) (0.02 µg mL(-1))) which was followed by 3-nitro-NPDO with CL(50) of 0.12 ± 0.03 µM L(-1) (0.035 µg mL(-1))) and 0.28 ± 0.08 µM L(-1) (0.08 µg mL(-1)) on A-549 and MCF-7 cells, respectively, while 1- and 4-nitro-quinoidals produced the least cytotoxic effects. Tumor cells quantified by AO/EB staining showed that the cell death induced by the compounds occurs primarily through apoptosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。